These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Understanding the drug-eluting stent trials. Coolong A; Kuntz RE Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349 [TBL] [Abstract][Full Text] [Related]
5. Restenosis related to percutaneous coronary intervention has been solved? Kivelä A; Hartikainen J Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432 [TBL] [Abstract][Full Text] [Related]
6. [Local drug administration systems, preclinical and clinical use: perspectives and limitations]. Gonschior P; Wilensky R; March K; Höfling B Z Kardiol; 1996 Mar; 85(3):155-65. PubMed ID: 8659193 [TBL] [Abstract][Full Text] [Related]
7. [Pathophysiology and pathobiochemistry of restenosis]. Höfling B; Gonschior P; Nikol S; Bauriedel G; Welsch U; Nerlich A Z Kardiol; 1994 May; 83(5):313-8. PubMed ID: 8053238 [TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stent: the emerging technique for the prevention of restenosis. Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626 [TBL] [Abstract][Full Text] [Related]
9. Update on PTCA: what are its limitations? Can they be overcome by new devices? A look at atherectomy, intra-arterial stents, and laser catheters. Feldman T; Moscucci M J Crit Illn; 1993 Apr; 8(4):461-78. PubMed ID: 10148463 [TBL] [Abstract][Full Text] [Related]
10. [Standards in interventional therapy of coronary artery disease]. Rutsch W; Gliech V; Dübel HP; Borges A; Theres H; Laule M; Baumann G Herz; 2002 Sep; 27(6):481-501. PubMed ID: 12378393 [TBL] [Abstract][Full Text] [Related]
15. [Coronary atherectomy. An essential tool for specific indications]. Coste P; Roudaut R; Besse P; Bonnet J Arch Mal Coeur Vaiss; 1999 Nov; 92(11 Suppl):1563-70. PubMed ID: 10598236 [TBL] [Abstract][Full Text] [Related]
16. [Are directional coronary atherectomy and Palmaz-Schatz stent more efficacious than conventional balloon angioplasty for treating de novo coronary artery lesions?]. Nanasato M; Adachi M; Hirayama H; Tsuji Y; Yamada T; Yoshida Y; Yamada K; Miwata S; Tsuboi N; Itoh T; Maeda S; Kuriyama K J Cardiol; 1997 Sep; 30(3):117-24. PubMed ID: 9309507 [TBL] [Abstract][Full Text] [Related]
17. [High frequency rotational angioplasty]. Haude M; Eick B; Baumgart D; Caspari G; Ge J; Liu F; Görge G; Erbel R Z Kardiol; 1996; 85 Suppl 1():17-23. PubMed ID: 8882820 [TBL] [Abstract][Full Text] [Related]
18. [New strategies in the treatment of restenosis]. von Hodenberg E; Tost B; Scheffold T Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555 [TBL] [Abstract][Full Text] [Related]
19. Use of locally delivered conventional drug therapies. Camenzind E; Kutryk MJ; Serruys PW Semin Interv Cardiol; 1996 Mar; 1(1):67-76. PubMed ID: 9552496 [TBL] [Abstract][Full Text] [Related]
20. The place of directional coronary atherectomy for the treatment of in-stent restenosis. Palacios IF; Sanchez PL; Mahdi NA Semin Interv Cardiol; 2000 Dec; 5(4):209-16. PubMed ID: 11244518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]